# Genentech, Inc. – FDA Inspection, Mar 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/genentech-inc/c630a432-31f9-476d-9f0d-9c7a9ed953d0
Source feed: FDA_Inspections

> FDA inspection 1233203 of Genentech, Inc., March 12, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 312. 34 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233203
- Company Name: Genentech, Inc.
- Inspection Date: 2024-03-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1332732 - 2026-08-04
- FDA Inspection 1322404 - 2026-05-15
- FDA Inspection 1314654 - 2026-04-07
- FDA Inspection 1263573 - 2025-04-21
- [FDA Inspection 1236964 - 2024-05-02](https://www.keypedia.com/records/fda_inspections/genentech-inc/d7fa8583-d22f-424b-8e09-2c1404f53842)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/dustin-r-abaonza/0a9994bd-d6ab-47cc-8f1b-5bf4d10bd852)

Company: https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
